Moteur de recherche d’entreprises européennes
Financement de l’UE (8 841 269 €) : Multi-agents d’IA pour révolutionner la prise en charge des maladies neurologiques Hor 08/04/2026 Programme de recherche et d'innovation de l'UE « Horizon »
Texte
Multi-agents d’IA pour révolutionner la prise en charge des maladies neurologiques
CEREBRIS is a groundbreaking project tackling one of the most pressing health challenges: neurological disease. These conditions now account for the highest share of global disability. By age 75, one in three people will be affected by a neurological condition, and one in five women will experience a stroke each year. These conditions disproportionately affect low- and middle-income countries. There is a critical need for solutions that are scalable, affordable, and personalised to patients. CEREBRIS aims to develop a secure, federated, and explainable AI ecosystem- starting with stroke care. Its AI models will be designed to form multiple types of patient data- such as brain scans, motion patterns and brain signals- to help doctors understand and predict more objectively how an individual is progressing and will recover after a brain injury. Using privacy-preserving technologies, the system will allow hospitals and clinicians to work together without ever sharing raw data, ensuring trust and compliance with global regulations. Long term, the platform will include multiple advanced clinical tools: AI Agents specialised in reasoning and prediction, signal integration and brain image synthesis, robotic and motion capture system to assess motor and sensory function, and an ethical biobank of real and simulated data for continuous learning. To enable this technological leap, a new comprehensive, longitudinal dataset from stroke survivors will be created- capturing geographic, clinical and real-world variations. Driven by a multidisciplinary European challenge-based consortium with deep expertise in neurology, AI, neurotechnology, and clinical translation, CEREBRIS will transform the entire stroke care pathway—from early diagnosis to recovery. By delivering precise diagnostics and targeted rehabilitation, CEREBRIS will significantly reduce long term disability, cut drastically healthcare expenses, and set a new standard for brain health globally,
| Aibili Associação para Investigacao Biomedica e Innovacao em Luz e Imagem | 411 545 € |
| G.TEC Medical Engineering GmbH | 352 500 € |
| Icometrix N.V. | 315 000 € |
| Katholieke Universiteit Leuven | 697 875 € |
| Lake Lucerne Institute AG | 935 335 € |
| Sano Centrum Zindywidualizowanej Medycyny Obliczeniowej Miedzynarodowa Fundacja Badawcza | 351 663 € |
| Stroke Alliance for Europe | 112 125 € |
| Universitaetsklinikum Hamburg-Eppendorf | 688 050 € |
| Universitat Zurich | 811 366 € |
| Universitetet I Oslo | 144 125 € |
| University College Dublin, National University of Ireland, Dublin | 639 843 € |
| University of Bath | 2 889 342 € |
| Vidavo SA | 113 125 € |
| Wise Angle Consulting SL | 379 375 € |
https://cordis.europa.eu/project/id/101257536
Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel.